Cell Therapy Account Management (CTAM)

The Cell Therapy Account Management (CTAM) role is responsible for driving demand for Amtagvi, the first FDA-approved cell therapy for advanced melanoma, by building a robust referral network between community practices and academic centers. This position serves as the primary commercial point of contact at authorized treatment centers, educating site personnel on clinical and product information while collaborating with internal teams to enhance operational excellence. The role focuses on enabling early patient identification, streamlining referral pathways, and sustaining the growth of the product through strategic account management and cross-functional collaboration.